FDA has accepted for Priority Review the biologics license application for linvoseltamab to treat adult patients with relapsed/refractory (R/R) multiple myeloma that has progressed after at least three prior therapies.
The FDA Oncology Center of Excellence published its 2023 annual report.
Mainz Biomed N.V. and Praxisdienst formed a distribution partnership focused on the accessibility of Mainz Biomed’s flagship product, ColoAlert.
A month after reporting to work in the top job at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Taofeek K. Owonikoko reflected on the obligations that come with being a Black director of an NCI-designated cancer center.
As NCI continues to hobble along on a flat budget provided by a succession of continuing resolutions, the prospects for robust funding for cancer research, rising paylines, and healthy cancer center support grants have dimmed for this fiscal year. “The extended delay in passing the FY2024 budget is disastrous for our cancer centers,” Jennifer W.... […]
We were thrilled to get “the call” from First Lady Jill Biden’s staff.
The 2023 San Antonio Breast Cancer Symposium (SABCS), held Dec. 5-9 at the city’s Henry B. Gonzalez Convention Center, had a record-setting attendance with 10,874 registered attendees from 102 countries.
Monica L. Baskin, an expert in health equity, was named deputy director of UPMC Hillman Cancer Center.
Steven A. Rosenberg, fellow of the AACR Academy, was named the recipient of the 2024 AACR Award for Lifetime Achievement in Cancer Research.
James S. Allan was named chair of the Foundation for Biomedical Research board of directors.
